Membrion Stock
A Seattle, WA-based manufacturer of ultra-low cost, high performance ion exchange membranes.
Sign up today and learn more about Membrion Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Membrion Stock
Membrion™ is a 2016 spin-out from the laboratories of the University of Washington (UW). Commercialization funding from the UW, the Murdock Charitable Trust, Amazon, the National Science Foundation (Award #1648517) and a consortium of California utilities (Rocket Fund) has helped to bridge the translation gap to a commercial product. In total, 11 different funding organizations have evaluated and financially supported Membrion's product development and commercialization plan. Most recently, that support has translated to private investment by angel investors as they scale their technology into commercial production.
Funding History
September 2018 | $748K |
---|---|
September 2018 | $1.0M |
December 2018 | $485K |
February 2019 | $3.1M |
Management
CTO
Greg Newbloom
President & CEO
John Plaza
Press
businesswire - Feb, 19 2024
Membrion named Top Innovator at World Economic Forumeinnews - Feb, 19 2024
Membrion names Thomas Mitchell as COOeu-startups - Jan, 27 2024
Lisbon-based LUGGit snaps €1.8 million to expand luggage ...valdostadailytimes - Jan, 27 2024
Membrion named Top Innovator at World Economic Forumeu-startups - Dec, 23 2023
Lisbon-based Membrion closes €11.4 million Series B to bring ...